11 items6 sources4 stocks
Zacks-Oct 28, 02:52 PM
GSK Q3 Earnings Top Mark, Stock Down on Soft Vaccines Sales - Zacks Investment Research
GSK Q3 Earnings Top Mark, Stock Down on Soft Vaccines Sales - Zacks Investment Research（摘要待生成）
Seeking Alpha-Oct 28, 07:42 AM
GSK delivers Q3 earnings beat, reaffirms 2026 outlook
GSK delivers Q3 earnings beat, reaffirms 2026 outlook（摘要待生成）
Seeking Alpha-Oct 28, 07:34 AM
GSK Non-GAAP EPS of £0.55 beats by £0.04, revenue of £8.89B beats by £50M; reaffirms FY outlook
GSK Non-GAAP EPS of £0.55 beats by £0.04, revenue of £8.89B beats by £50M; reaffirms FY outlook（摘要待生成）
Barron's-Oct 28, 02:15 PM
What GSK Needs to Do After Weak Vaccine Sales Spoil an Earnings Beat
What GSK Needs to Do After Weak Vaccine Sales Spoil an Earnings Beat（摘要待生成）
Benzinga-Oct 28, 01:25 PM
GSK Q3 2026 Earnings Call Transcript - Benzinga
GSK Q3 2026 Earnings Call Transcript - Benzinga（摘要待生成）
Investing.com-Oct 28, 07:43 AM
GSK beats Q3 profit estimates on specialty medicines strength
GSK beats Q3 profit estimates on specialty medicines strength（摘要待生成）
Seeking Alpha-Oct 28, 08:27 AM
GSK declares $0.4524/ADS or 17p/share dividend
GSK declares $0.4524/ADS or 17p/share dividend（摘要待生成）
GSKshareholder_returns
Investing.com-Oct 26, 07:38 AM
GSK cancer drug clears rectal tumours in 76% of patients in trial, data shows
GSK cancer drug clears rectal tumours in 76% of patients in trial, data shows（摘要待生成）
GSKhealthcare
Investing.com-Oct 21, 06:21 AM
FDA approves GSK’s Hibsago for chronic hepatitis B treatment
FDA approves GSK’s Hibsago for chronic hepatitis B treatment（摘要待生成）